[Eye movement disorders in children].

Bobylova MIu, Mironov MB, Mukhin KIu, Petrukhin AS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(1 Pt 2):81-92. Russian.

Neuromodulation for movement disorders.

Dallapiazza R, McKisic MS, Shah B, Elias WJ.

Neurosurg Clin N Am. 2014 Jan;25(1):47-58. doi: 10.1016/j.nec.2013.08.002. Review.

Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

Quik M, Zhang D, Perez XA, Bordia T.

Pharmacol Ther. 2014 Oct;144(1):50-9. doi: 10.1016/j.pharmthera.2014.05.004. Review.

Movement disorders.

Al-Baradie RS.

Neurosciences (Riyadh). 2014 Oct;19(4):341-2. No abstract available.

Medical marijuana use in a movement disorders clinic in Rhode Island."

Friedman JH.

Parkinsonism Relat Disord. 2014 Nov;20(11):1293-4. doi: 10.1016/j.parkreldis.2014.07.006. No abstract available.

Acute and subacute drug-induced movement disorders.

Burkhard PR.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S108-12. doi: 10.1016/S1353-8020(13)70027-0. Review.

Multifunctional wearable devices for diagnosis and therapy of movement disorders.

Son D, Lee J, Qiao S, Ghaffari R, Kim J, Lee JE, Song C, Kim SJ, Lee DJ, Jun SW, Yang S, Park M, Shin J, Do K, Lee M, Kang K, Hwang CS, Lu N, Hyeon T, Kim DH.

Nat Nanotechnol. 2014 May;9(5):397-404. doi: 10.1038/nnano.2014.38.

De novo SCN8A mutation identified by whole-exome sequencing in a boy with neonatal epileptic encephalopathy, multiple congenital anomalies, and movement disorders.

Vaher U, Nõukas M, Nikopensius T, Kals M, Annilo T, Nelis M, Ounap K, Reimand T, Talvik I, Ilves P, Piirsoo A, Seppet E, Metspalu A, Talvik T.

J Child Neurol. 2014 Dec;29(12):NP202-6. doi: 10.1177/0883073813511300.

Movement disorders associated with spontaneous CSF leaks: a case series.

Mokri B.

Cephalalgia. 2014 Dec;34(14):1134-41. doi: 10.1177/0333102414531154.

[Movement disorders].

Bereau M, Tranchant C.

Rev Prat. 2014 Apr;64(4):561-3, 565-7. French. No abstract available.

Acute movement disorders associated with the use of second-generation antipsychotics in borderline personality disorder: a meta-analysis.

Willems AE, Tenback DE, Ingenhoven TJ, van Harten PN.

J Clin Psychopharmacol. 2014 Aug;34(4):520-2. doi: 10.1097/JCP.0000000000000152. No abstract available.

Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.

Bártová P, Kraft O, Bernátek J, Havel M, Ressner P, Langová K, Herzig R, Skoloudík D.

Ultrasound Med Biol. 2014 Oct;40(10):2365-71. doi: 10.1016/j.ultrasmedbio.2014.05.014.

Movement disorders in neuroleptic-naïve patients with schizophrenia spectrum disorders.

Ayehu M, Shibre T, Milkias B, Fekadu A.

BMC Psychiatry. 2014 Oct 9;14:280. doi: 10.1186/s12888-014-0280-1.

Movement disorders: new insights into disease mechanisms and treatment.

Poewe W, Mahlknecht P.

Lancet Neurol. 2014 Jan;13(1):9-11. doi: 10.1016/S1474-4422(13)70288-6. Review. No abstract available.

Movement disorders.

Al-Baradie RS.

Neurosciences (Riyadh). 2014 Oct;19(4):341-2. No abstract available.